Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
0.000001 USD | -.--% | -.--% | -.--% |
2016 | Transcript : EPIRUS Biopharmaceuticals, Inc., Q4 2015 Earnings Call, Mar 15, 2016 | |
2015 | Transcript : EPIRUS Biopharmaceuticals, Inc., Q3 2015 Earnings Call, Nov 16, 2015 |
Volumen
MärkteBasisdaten
Extremkurse
Indikatoren
Sektorenvergleich - Biotechnologie und medizinische Forschung - Andere
Name | % | % 5 Tage | % 1. Jan. | % 1 Jahr | Kap. | |
---|---|---|---|---|---|---|
-.--% | -.--% | - | - | 26 | ||
+0.17% | +13.29% | +33.63% | +5.28% | 50.93 Mrd. | ||
-1.63% | -1.24% | -0.09% | +15.91% | 42.12 Mrd. | ||
+0.34% | +0.57% | +49.62% | -8.44% | 42.05 Mrd. | ||
-0.78% | -0.73% | -4.96% | +10.12% | 29.18 Mrd. | ||
-0.35% | -0.21% | +11.18% | +47.91% | 26.02 Mrd. | ||
-1.20% | -0.71% | -21.95% | -21.67% | 18.9 Mrd. | ||
+1.16% | +3.58% | +8.61% | -0.09% | 13.21 Mrd. | ||
+0.75% | +3.78% | +24.73% | +24.91% | 12.17 Mrd. | ||
+0.01% | +0.80% | +28.31% | +86.50% | 12.16 Mrd. | ||
-1.40% | -2.85% | -6.26% | +11.74% | 11.42 Mrd. | ||
-0.65% | +4.77% | +2.05% | -1.84% | 10.14 Mrd. | ||
-0.93% | +8.63% | +39.38% | -4.38% | 7.48 Mrd. | ||
-1.58% | -1.63% | +13.79% | +91.74% | 6.57 Mrd. | ||
+1.08% | +5.80% | +37.41% | +52.46% | 6.5 Mrd. | ||
-1.89% | -4.52% | +3.67% | -36.22% | 6.41 Mrd. | ||
Durchschnitt | -0.43% | +2.04% | +14.61% | +18.26% | ||
Gewichteter Durchschnitt nach Marktkapitalisierung | -0.41% | +2.75% | +16.55% | +13.09% |
Historische Daten
Datum | Eröffnung | Hoch | Tief | Schlusskurs | Volumen |
---|
Monatliche Veränderungen
Jährliche Veränderungen
2021 | -99.09% | ||
2020 | +1’122.22% | ||
2019 | +125.00% | ||
2018 | -85.71% | ||
2017 | -90.18% | ||
2016 | -99.08% | ||
2015 | -45.50% | ||
2014 | -48.92% | ||
2013 | -71.54% | ||
2012 | -46.28% | ||
2011 | -23.42% | ||
2010 | +90.36% | ||
2009 | +33.87% | ||
2008 | -86.04% | ||
2007 | -48.73% | ||
2006 | +5.87% |
- Börse
- Aktien
- A117U3 Aktie
- Kurse EPIRUS Biopharmaceuticals, Inc.